Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIFI vs QLB Type 3 Block in THA
NCT06838156Completed
- Sponsor
- Başakşehir Çam & Sakura City Hospital
- Start
- Feb 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Başakşehir Çam & Sakura City Hospital. Primary endpoint: Effect on pain score at 24 hours. Started Feb 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06838156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06838156.